Related Experiment Videos
Herpes simplex virus hepatitis in pregnancy. A case report
1Department of Obstetrics and Gynecology, Bethesda Hospital, Cincinnati, Ohio.
The Journal of Reproductive Medicine
|July 1, 1994
Summary
Hepatitis from herpes simplex virus is rare but dangerous, especially during pregnancy. Treatment with acyclovir may significantly reduce maternal and fetal mortality rates.
Area of Science:
- Hepatology
- Virology
- Obstetrics
Background:
- Hepatitis is a serious complication of herpes simplex virus (HSV) infection.
- Pregnancy is identified as a significant risk factor for severe outcomes in HSV hepatitis.
- HSV hepatitis during pregnancy is associated with high maternal and fetal mortality.
Observation:
- The clinical presentation and outcomes of HSV hepatitis in pregnant patients were evaluated.
- Maternal and fetal mortality rates associated with this condition were analyzed.
Findings:
- Acyclovir treatment was associated with improved outcomes in cases of herpes simplex virus hepatitis.
- The use of acyclovir demonstrated a potential to reduce mortality in pregnant women and their fetuses.
Implications:
- Early diagnosis and prompt treatment with acyclovir are crucial for managing HSV hepatitis in pregnancy.
- Antiviral therapy with acyclovir represents a key strategy to improve maternal and fetal survival rates.
- Further research into HSV hepatitis during pregnancy may refine treatment protocols and enhance patient care.